[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349238-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349238-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-the-bmx-in-cancer-molecular-mechanisms-and-emerging-therapeutic-strategies","Targeting the BMX in cancer - molecular mechanisms and emerging therapeutic strategies","","Bone Marrow Tyrosine Kinase on chromosome X (BMX), also termed epithelial/endothelial cell kinase (etK), is a core TEC-family non-receptor tyrosine kinase. The review details BMX’s modular structure (PH, tH/BH, SH3, SH2 and catalytic kinase domains) and explains how these features connect to signaling specificity and oncogenic behavior. It covers BMX functions in proliferation, apoptosis, invasion, metastasis, cancer stemness, angiogenesis and drug resistance, and summarizes advances in BMX inhibitor research to support BMX-targeted cancer therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-the-bmx-in-cancer-molecular-mechanisms-and-emerging-therapeutic-strategies/349238/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-the-bmx-in-cancer-molecular-mechanisms-and-emerging-therapeutic-strategies/349238.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is BMX and why is it important in cancer?","Question",{"text":63,"@type":64},"BMX is a TEC-family non-receptor tyrosine kinase (also known as etK) reported to be highly expressed and to play an oncogenic role in various cancers through multiple signaling processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which BMX functions are addressed in the review?",{"text":68,"@type":64},"The review focuses on BMX roles in tumour cell proliferation, apoptosis, invasion, metastasis, cancer stem cell properties, angiogenesis, and drug resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the main structural domains of BMX mentioned?",{"text":72,"@type":64},"BMX contains an N-terminal PH domain, a BH domain, SH2 and SH3 domains, and a C-terminal catalytic tyrosine kinase domain, forming a modular architecture that enables diverse cellular signalling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349238,1790173185,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Journal of EnzymE InhIbItIon and mEdIcInal chEmIstry 2026, Vol. 41, no. 1, 2677282  \n[https://doi.org/10.1080/14756366.2026.2677282](https://doi.org/10.1080/14756366.2026.2677282)  \nReview ARticle    \nTargeting the BMX in cancer: molecular mechanisms and emerging therapeutic strategies  \nMan Zhanga\\#, Jinchi chena\\#, Rong lianga\\#, wei Jianga, Min lina, Siqi wena, Dejun liua, Bei Yia, Ruiqi chenb, tianyu chenb and Zhao lia  \nadepartment of Experimental research, Guangxi medical university cancer hospital, nanning, china; bdepartment of Gastrointestinal surgery, Guangxi clinical research center for colorectal cancer, Guangxi medical university cancer hospital, nanning, china  \nABSTRACT  \nBone Marrow tyrosine Kinase on chromosome X (BMX), also known as epithelial/ endothelial cell kinase (etK), is a core member of the tec family of non-receptor tyrosine kinases. Structurally, BMX kinase contains an N-terminal PH domain, a BH domain, a SH2 domain, a SH3 domain and a c-terminal catalytic tyrosine kinase domain. this distinctive modular architecture enables BMX to engage in diverse cellular signalling [cascades. it](cascades. it) has been reported that BMX is highly expressed and plays an oncogenic role in various [cancers. in](cancers. in) this paper, we mainly explore the function and mechanism of BMX in tumour cell proliferation, apoptosis, invasion, metastasis, cancer stem cell properties, angiogenesis and drug resistance. Furthermore, the research focus on summarising the research progress of BMX inhibitors for cancer treatment. this review aims to provide a theoretical framework for cancer therapy by targeting BMX.  \nIntroduction  \nARTICLE HISTORY  \nReceived 10 March 2026 Revised 19 April 2026 Accepted 14 May 2026  \nKEYWORDS  \nBMX; proliferation; apoptosis; stemness; drug resistance  \nBone Marrow tyrosine Kinase on chromosome X (BMX), also known as epithelial/endothelial cell kinase (etK) . it is located in the Xp22.2 region of X chromosome between the genetic markers DXS197 and DXS207 . the gene encodes a protein consisting of 675 amino acids1. the protein structure of BMX (Figure 1) was retrieved from the Protein Data Bank ([https://www.rcsb.org/](https://www.rcsb.org/); PDB iD: 6i99) and rendered using PyMOl. BMX belongs to the tec family of non-receptor tyrosine kinases and shares the characteristic modular architecture conserved among Btk, itk, tec and txk, which comprises an N-terminal pleckstrin homology (PH) domain, a tec homology (tH) domain, Src homology 3 (SH3) and SH2 domains, anda c-terminal kinase domain2 (Figure 2) . the N-terminal PH domain of approximately 100 residues mediates membrane localisation and protein–protein interactions by binding to phosphatidylinositol (3,4,5)-trisphosphate (PiP3), which is essential for upstream activation3. the tH domain of around 80 residues contains a zinc-coordinating Btk-homology (BH) motif but lacks the proline-rich region (PRR) found in other tec kinases; its structural integrity is critical for BMX activity4. Distinct from other family members, the SH3 domain of approximately 60 residues is intrinsically disordered in solution, as demonstrated by hydrogen-deuterium exchange mass spectrometry and NMR spectroscopy, this disorder prevents canonical PXXP ligand interactions, and autophosphorylation at tyr215 is required for full activation and substrate engagement5,6. the adjacent SH2 domain of roughly 100 residues recognises thephosphotyrosine-Xaa-asparagine (pYxN) motif, mediating interactions with activated receptor tyrosine kinases or adaptor proteins and recruiting BMX to signalling complexes to achieve substrate specificity7,8. the kinase domain of BMX exhibits the canonical bilobed architecture, with the AtP-binding  \nCONTACT zhao li  zhaoli1989041[1@163.com](1@163.com)  department of Experimental research, Guangxi medical university cancer hospital, nanning, china  \n\\#these authors contributed equally to this study.  \n© 2026 the author(s) . Published by Informa uK l","cbCaiveEOv7BXZIw","https://ap.wps.com/l/cbCaiveEOv7BXZIw","pdf",1653582,26,"English","# Introduction\n# ARTICLE HISTORY\n# KEYWORDS\n# Structural domains and activation mechanisms\n# Therapeutic implications of BMX inhibitors","[{\"question\":\"What is BMX and why is it important in cancer?\",\"answer\":\"BMX is a TEC-family non-receptor tyrosine kinase (also known as etK) reported to be highly expressed and to play an oncogenic role in various cancers through multiple signaling processes.\"},{\"question\":\"Which BMX functions are addressed in the review?\",\"answer\":\"The review focuses on BMX roles in tumour cell proliferation, apoptosis, invasion, metastasis, cancer stem cell properties, angiogenesis, and drug resistance.\"},{\"question\":\"What are the main structural domains of BMX mentioned?\",\"answer\":\"BMX contains an N-terminal PH domain, a BH domain, SH2 and SH3 domains, and a C-terminal catalytic tyrosine kinase domain, forming a modular architecture that enables diverse cellular signalling.\"}]","Targeting the BMX in cancer - molecular mechanisms and emerging therapeutic strategies | PDF",1790082350,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e57686829f9451f8f7d6a25622943905.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cdeeb3480dd9e54f26429f6507aba99.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7fbeec19c8b8111fdbd247e8ef7586c.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad1275344483525d97a631afcdc2acf9.webp",980,1306]